Page results
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
-
The primary objective of the ENT urgent referral clinic is to provide speedy access and effective care to all adult and paediatric patients aged above two years old with urgent ENT problems.
-
Advice on managing education for young people living with fatigue conditions.
-
Advice on relaxation techniques for young people living with fatigue conditions.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing, and tissue diagnosis.
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
The department specialises in the assessment and management of Complex Neuropsychiatric conditions occurring in the context of neurological disease.
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment